Perindopril erbumine and Sectral drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Perindopril erbumine (perindopril erbumine) and Sectral (acebutolol hydrochloride). Common drug interactions include abdominal pain upper among females and eosinophilia among males.

The phase IV clinical study analyzes what interactions people have when they take Perindopril erbumine and Sectral. It is created by eHealthMe based on reports of 65 people who take the same drugs from the FDA, and is updated regularly.

What is Perindopril erbumine?

Perindopril erbumine has active ingredients of perindopril erbumine. It is often used in high blood pressure. eHealthMe is studying from 8,958 Perindopril erbumine users. Check the latest studies of Perindopril erbumine.

What is Sectral?

Sectral has active ingredients of acebutolol hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 3,548 Sectral users. Check the latest studies of Sectral.



On Jul, 28, 2026

65 people who take Perindopril erbumine and Sectral together, and have interactions are studied.

Perindopril erbumine and Sectral drug interactions.

What are the common drug interactions of Perindopril Erbumine and Sectral, by gender? *:

female:

  1. Abdominal pain upper
  2. Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
  3. Anaemia (lack of blood)
  4. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  5. Back pain
  6. Bladder discomfort
  7. Blood cholesterol increased
  8. Blood pressure decreased
  9. Cardiac failure
  10. Carotid artery stenosis (narrowing of carotid artery)

male:

  1. Eosinophilia (eosinophil count in the peripheral blood exceeds)
  2. Nephrotic syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema)
  3. Rash papular (redness with papule)
  4. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  5. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  6. Sepsis (a severe blood infection that can lead to organ failure and death)
  7. Blood creatinine increased
  8. Blood glucose increased
  9. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  10. Cardiomyopathy (weakening of the heart muscle)

What are the common drug interactions of Perindopril Erbumine and Sectral, by age (0-1 to 60+)? *:

0-1:

  1. Cheilitis (infection of lips)
  2. Eosinophilia (eosinophil count in the peripheral blood exceeds)
  3. Eyelid oedema (eyelids are swollen and contain excessive fluid)
  4. Generalised erythema (redness of the skin all over the body)
  5. Hyperthermia (body temperature greatly above normal)
  6. Pruritus generalised (generalized itching)

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)

40-49:

  1. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  2. Ventricular fibrillation (abnormally irregular heart rhythm)
  3. Immunosuppressant drug level decreased

50-59:

  1. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  2. Eosinophilia (eosinophil count in the peripheral blood exceeds)
  3. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  4. Neutropenia (an abnormally low number of neutrophils)
  5. Peripheral sensorimotor neuropathy (damage to one or more of your peripheral nerves)
  6. Toxic skin eruption (skin breakdown due to toxic substance)
  7. Anaemia (lack of blood)
  8. Blood lactic acid increased
  9. Calculus ureteric (stone in ureter)
  10. Cholecystitis chronic (long lasting infection of gallbladder)

60+:

  1. Nephrotic syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema)
  2. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  3. Hyperkalaemia (damage to or disease of the kidney)
  4. Renal failure acute (rapid kidney dysfunction)
  5. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  6. Blood creatinine increased
  7. Blood glucose increased
  8. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
  9. Cardiomyopathy (weakening of the heart muscle)
  10. Cell death

What are the existing conditions these people have? *

  1. Hiv Infection: 6 people, 9.23%
  2. Heart Attack: 5 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Perindopril erbumine and Sectral?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Perindopril erbumine and Sectral:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Perindopril erbumine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Sectral:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Perindopril erbumine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sectral and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on perindopril erbumine and acebutolol hydrochloride (the active ingredients of Perindopril erbumine and Sectral, respectively), and Perindopril erbumine and Sectral (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: